Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome

Authors

Rachel L Henson, Washington University School of Medicine in St. Louis
Eric Doran, University of California-Irvine
Bradley T Christian, University of Wisconsin-Madison
Benjamin L Handen, University of Pittsburgh
William E Klunk, University of Pittsburgh
Florence Lai, Harvard University
Joseph H Lee, Columbia University
H Diana Rosas, Harvard University
Nicole Schupf, Columbia University
Shahid H Zaman, University of Cambridge
Ira T Lott, University of California-Irvine
Anne M Fagan, Washington University School of Medicine in St. Louis

Journal

Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring

Publication Date

1-1-2020

Volume

12

Issue

1

First Page

e12057

Document Type

Open Access Publication

DOI

10.1002/dad2.12057

Rights and Permissions

Henson, RL, Doran, E, Christian, BT, et al. Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome. Alzheimer's Dement. 2020; 12:e12057. https://doi.org/10.1002/dad2.12057 © 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Recommended Citation

Henson, Rachel L; Doran, Eric; Christian, Bradley T; Handen, Benjamin L; Klunk, William E; Lai, Florence; Lee, Joseph H; Rosas, H Diana; Schupf, Nicole; Zaman, Shahid H; Lott, Ira T; and Fagan, Anne M, "Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome." Alzheimers & Dementia: Diagnosis, Assessment & Disease Monitoring. 12, 1. e12057 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/11403